Symbol Lookup

Tuesday May 24, 2016 11:16 PM ET. Data delayed 15 minutes.
0.00 (4.60%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Guided Therapeutics Reports Record First Quarter 2016 Results
8:37AM ET on Thursday May 19, 2016 by Business Wire

--$262,000 of sales in 1Q 2016, a 106% increase from 2015

--Record number of disposable LuViva(R) Cervical Guides shipped in Q1

--Nearing 100 LuVivas shipped worldwide

--Continued growth in the Middle East and Southeast Asi...

Guided Therapeutics Ships First LuViva(R) Advanced Cervical Scan for the Dominican Republic
8:30AM ET on Wednesday May 11, 2016 by Business Wire

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today shipment of the first LuViva(R) Advanced Cervical Scan for the Domini...

Company Information

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices. The Company's primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The Company's technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The Company focuses on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage. Its product, in addition to detecting the structural changes attributed to cervical cancer, is also detects the biochemical changes that precede the development of visual lesions. LuViva consists of three components: Touch screen monitor, Hand Held Unit (HHU) and the Wheeled Base.


Headquarters5835 Peachtree Cors E Ste D
NORCROSS, GA, United States 30092-3413


Independent Chairman and DirectorMichael James
Chief Executive Officer, Acting Chief Financial Officer, President and DirectorGene Cartwright
Senior Vice President - EngineeringRichard Fowler
Independent DirectorJohn Imhoff
Independent DirectorJonathan Niloff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$714.2KBeta0.25
Revenue (TTM)$606.0KEPS$-7.20
Shares Out.29.9MBook Value$-2.35
Guided Therapeutics Inc does not pay a dividend.P/E--
Price/Sales (TTM)1.2
P/Cash Flow (TTM)--
Operating Margin-1,027.56%

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample